nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Seasonal allergy—Metformin—polycystic ovary syndrome	0.0335	0.0752	CcSEcCtD
Gabapentin—Function kidney decreased—Metformin—polycystic ovary syndrome	0.0322	0.0721	CcSEcCtD
Gabapentin—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.0322	0.0721	CcSEcCtD
Gabapentin—Viral diarrhoea—Metformin—polycystic ovary syndrome	0.0269	0.0603	CcSEcCtD
Gabapentin—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0246	0.0551	CcSEcCtD
Gabapentin—CACNA1B—pituitary gland—polycystic ovary syndrome	0.0207	0.0774	CbGeAlD
Gabapentin—BCAT1—endometrium—polycystic ovary syndrome	0.018	0.0673	CbGeAlD
Gabapentin—Tooth abscess—Metformin—polycystic ovary syndrome	0.0168	0.0377	CcSEcCtD
Gabapentin—BCAT1—uterus—polycystic ovary syndrome	0.0166	0.062	CbGeAlD
Gabapentin—BCAT1—pituitary gland—polycystic ovary syndrome	0.0163	0.0609	CbGeAlD
Gabapentin—BCAT1—adipose tissue—polycystic ovary syndrome	0.0162	0.0606	CbGeAlD
Gabapentin—CACNA2D2—pituitary gland—polycystic ovary syndrome	0.0149	0.0558	CbGeAlD
Gabapentin—BCAT1—adrenal gland—polycystic ovary syndrome	0.0145	0.0544	CbGeAlD
Gabapentin—BCAT1—female gonad—polycystic ovary syndrome	0.0136	0.0507	CbGeAlD
Gabapentin—BCAT1—vagina—polycystic ovary syndrome	0.0135	0.0504	CbGeAlD
Gabapentin—CACNA2D2—adrenal gland—polycystic ovary syndrome	0.0133	0.0499	CbGeAlD
Gabapentin—BCAT1—endocrine gland—polycystic ovary syndrome	0.0126	0.0471	CbGeAlD
Gabapentin—CACNA2D2—vagina—polycystic ovary syndrome	0.0124	0.0462	CbGeAlD
Gabapentin—CACNA2D2—endocrine gland—polycystic ovary syndrome	0.0116	0.0432	CbGeAlD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—polycystic ovary syndrome	0.0109	0.038	CbGpPWpGaD
Gabapentin—Nail disorder—Metformin—polycystic ovary syndrome	0.0108	0.0243	CcSEcCtD
Gabapentin—CACNA2D1—adipose tissue—polycystic ovary syndrome	0.0107	0.04	CbGeAlD
Gabapentin—ADORA1—adipose tissue—polycystic ovary syndrome	0.0103	0.0386	CbGeAlD
Gabapentin—CACNA2D1—adrenal gland—polycystic ovary syndrome	0.0096	0.0359	CbGeAlD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SUOX—polycystic ovary syndrome	0.00944	0.033	CbGpPWpGaD
Gabapentin—CACNA2D1—female gonad—polycystic ovary syndrome	0.00895	0.0334	CbGeAlD
Gabapentin—CACNA2D1—vagina—polycystic ovary syndrome	0.00889	0.0332	CbGeAlD
Gabapentin—ADORA1—vagina—polycystic ovary syndrome	0.00858	0.0321	CbGeAlD
Gabapentin—CACNA2D1—endocrine gland—polycystic ovary syndrome	0.00832	0.0311	CbGeAlD
Gabapentin—Contusion—Metformin—polycystic ovary syndrome	0.00806	0.0181	CcSEcCtD
Gabapentin—ADORA1—endocrine gland—polycystic ovary syndrome	0.00803	0.03	CbGeAlD
Gabapentin—Accidental injury—Metformin—polycystic ovary syndrome	0.00794	0.0178	CcSEcCtD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—polycystic ovary syndrome	0.00744	0.026	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.00689	0.0241	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.0067	0.0234	CbGpPWpGaD
Gabapentin—Neuropathy—Metformin—polycystic ovary syndrome	0.0066	0.0148	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TFRC—polycystic ovary syndrome	0.00623	0.0218	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L2—polycystic ovary syndrome	0.00617	0.0216	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—polycystic ovary syndrome	0.00606	0.0212	CbGpPWpGaD
Gabapentin—Ear pain—Metformin—polycystic ovary syndrome	0.00598	0.0134	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—CCNB1—polycystic ovary syndrome	0.00561	0.0196	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00555	0.0194	CbGpPWpGaD
Gabapentin—Injury—Metformin—polycystic ovary syndrome	0.00555	0.0124	CcSEcCtD
Gabapentin—Renal impairment—Metformin—polycystic ovary syndrome	0.00536	0.012	CcSEcCtD
Gabapentin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00523	0.0117	CcSEcCtD
Gabapentin—Lethargy—Metformin—polycystic ovary syndrome	0.00521	0.0117	CcSEcCtD
Gabapentin—Pain in extremity—Metformin—polycystic ovary syndrome	0.0051	0.0114	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.00508	0.0178	CbGpPWpGaD
Gabapentin—Migraine—Metformin—polycystic ovary syndrome	0.00502	0.0113	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00489	0.0171	CbGpPWpGaD
Gabapentin—Dehydration—Metformin—polycystic ovary syndrome	0.00474	0.0106	CcSEcCtD
Gabapentin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00471	0.0106	CcSEcCtD
Gabapentin—Breast disorder—Metformin—polycystic ovary syndrome	0.00461	0.0103	CcSEcCtD
Gabapentin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00456	0.0102	CcSEcCtD
Gabapentin—Influenza—Metformin—polycystic ovary syndrome	0.00441	0.00988	CcSEcCtD
Gabapentin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00432	0.00969	CcSEcCtD
Gabapentin—Angina pectoris—Metformin—polycystic ovary syndrome	0.0043	0.00963	CcSEcCtD
Gabapentin—Sweating increased—Metformin—polycystic ovary syndrome	0.0043	0.00963	CcSEcCtD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—polycystic ovary syndrome	0.00415	0.0145	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BAX—polycystic ovary syndrome	0.00413	0.0144	CbGpPWpGaD
Gabapentin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0041	0.00918	CcSEcCtD
Gabapentin—Infestation—Metformin—polycystic ovary syndrome	0.00393	0.00881	CcSEcCtD
Gabapentin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00393	0.00881	CcSEcCtD
Gabapentin—Drowsiness—Metformin—polycystic ovary syndrome	0.00393	0.00881	CcSEcCtD
Gabapentin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00385	0.00864	CcSEcCtD
Gabapentin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00372	0.00833	CcSEcCtD
Gabapentin—Bradycardia—Metformin—polycystic ovary syndrome	0.00359	0.00805	CcSEcCtD
Gabapentin—Rhinitis—Metformin—polycystic ovary syndrome	0.00354	0.00793	CcSEcCtD
Gabapentin—Hepatitis—Metformin—polycystic ovary syndrome	0.00353	0.00791	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00352	0.0123	CbGpPWpGaD
Gabapentin—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00351	0.00787	CcSEcCtD
Gabapentin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00348	0.00779	CcSEcCtD
Gabapentin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00347	0.00777	CcSEcCtD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L2—polycystic ovary syndrome	0.00344	0.012	CbGpPWpGaD
Gabapentin—Eye disorder—Metformin—polycystic ovary syndrome	0.0033	0.00739	CcSEcCtD
Gabapentin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00328	0.00734	CcSEcCtD
Gabapentin—Immune system disorder—Metformin—polycystic ovary syndrome	0.00319	0.00714	CcSEcCtD
Gabapentin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00318	0.00713	CcSEcCtD
Gabapentin—Chills—Metformin—polycystic ovary syndrome	0.00317	0.0071	CcSEcCtD
Gabapentin—Erythema—Metformin—polycystic ovary syndrome	0.00307	0.00688	CcSEcCtD
Gabapentin—Malnutrition—Metformin—polycystic ovary syndrome	0.00307	0.00688	CcSEcCtD
Gabapentin—Flatulence—Metformin—polycystic ovary syndrome	0.00303	0.00678	CcSEcCtD
Gabapentin—Dysgeusia—Metformin—polycystic ovary syndrome	0.00301	0.00674	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—NPB—polycystic ovary syndrome	0.00297	0.0104	CbGpPWpGaD
Gabapentin—Muscle spasms—Metformin—polycystic ovary syndrome	0.00295	0.00662	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.00292	0.0102	CbGpPWpGaD
Gabapentin—Vision blurred—Metformin—polycystic ovary syndrome	0.0029	0.00649	CcSEcCtD
Gabapentin—Tremor—Metformin—polycystic ovary syndrome	0.00288	0.00645	CcSEcCtD
Gabapentin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00285	0.00639	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00278	0.00973	CbGpPWpGaD
Gabapentin—Malaise—Metformin—polycystic ovary syndrome	0.00277	0.00621	CcSEcCtD
Gabapentin—Syncope—Metformin—polycystic ovary syndrome	0.00276	0.00617	CcSEcCtD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00275	0.00961	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—TH—polycystic ovary syndrome	0.00272	0.00952	CbGpPWpGaD
Gabapentin—Palpitations—Metformin—polycystic ovary syndrome	0.00272	0.00608	CcSEcCtD
Gabapentin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0027	0.00605	CcSEcCtD
Gabapentin—Hypertension—Metformin—polycystic ovary syndrome	0.00265	0.00594	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00264	0.00923	CbGpPWpGaD
Gabapentin—Chest pain—Metformin—polycystic ovary syndrome	0.00262	0.00586	CcSEcCtD
Gabapentin—Myalgia—Metformin—polycystic ovary syndrome	0.00262	0.00586	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0026	0.00582	CcSEcCtD
Gabapentin—Discomfort—Metformin—polycystic ovary syndrome	0.00258	0.00579	CcSEcCtD
Gabapentin—Oedema—Metformin—polycystic ovary syndrome	0.00251	0.00562	CcSEcCtD
Gabapentin—Infection—Metformin—polycystic ovary syndrome	0.00249	0.00558	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.00248	0.00866	CbGpPWpGaD
Gabapentin—Shock—Metformin—polycystic ovary syndrome	0.00247	0.00553	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00246	0.0086	CbGpPWpGaD
Gabapentin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00246	0.00551	CcSEcCtD
Gabapentin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00246	0.0055	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00245	0.00856	CbGpPWpGaD
Gabapentin—Skin disorder—Metformin—polycystic ovary syndrome	0.00244	0.00546	CcSEcCtD
Gabapentin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00242	0.00543	CcSEcCtD
Gabapentin—Anorexia—Metformin—polycystic ovary syndrome	0.00239	0.00536	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00236	0.00825	CbGpPWpGaD
Gabapentin—Hypotension—Metformin—polycystic ovary syndrome	0.00234	0.00525	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00231	0.00806	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.0023	0.00804	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.0023	0.00804	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00228	0.00512	CcSEcCtD
Gabapentin—Paraesthesia—Metformin—polycystic ovary syndrome	0.00225	0.00505	CcSEcCtD
Gabapentin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00224	0.00501	CcSEcCtD
Gabapentin—Somnolence—Metformin—polycystic ovary syndrome	0.00223	0.005	CcSEcCtD
Gabapentin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00221	0.00495	CcSEcCtD
Gabapentin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00218	0.00488	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00216	0.00485	CcSEcCtD
Gabapentin—CACNA2D2—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.00216	0.00756	CbGpPWpGaD
Gabapentin—Fatigue—Metformin—polycystic ovary syndrome	0.00216	0.00484	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00215	0.00752	CbGpPWpGaD
Gabapentin—Constipation—Metformin—polycystic ovary syndrome	0.00214	0.00481	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00213	0.00745	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00209	0.0073	CbGpPWpGaD
Gabapentin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00207	0.00463	CcSEcCtD
Gabapentin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00205	0.00459	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00203	0.0071	CbGpPWpGaD
Gabapentin—Urticaria—Metformin—polycystic ovary syndrome	0.00199	0.00446	CcSEcCtD
Gabapentin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00198	0.00444	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00197	0.00689	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00197	0.00689	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NMNAT3—polycystic ovary syndrome	0.0019	0.00663	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—DLG4—polycystic ovary syndrome	0.00189	0.00659	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00184	0.00644	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00184	0.00644	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00184	0.00644	CbGpPWpGaD
Gabapentin—Asthenia—Metformin—polycystic ovary syndrome	0.0018	0.00403	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.0018	0.00628	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00179	0.00625	CbGpPWpGaD
Gabapentin—Pruritus—Metformin—polycystic ovary syndrome	0.00177	0.00398	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00174	0.00608	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00173	0.00606	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SUOX—polycystic ovary syndrome	0.00173	0.00606	CbGpPWpGaD
Gabapentin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00172	0.00384	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00168	0.00588	CbGpPWpGaD
Gabapentin—Dizziness—Metformin—polycystic ovary syndrome	0.00166	0.00372	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00163	0.0057	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00161	0.00564	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.0016	0.00559	CbGpPWpGaD
Gabapentin—Vomiting—Metformin—polycystic ovary syndrome	0.00159	0.00357	CcSEcCtD
Gabapentin—Rash—Metformin—polycystic ovary syndrome	0.00158	0.00354	CcSEcCtD
Gabapentin—Dermatitis—Metformin—polycystic ovary syndrome	0.00158	0.00354	CcSEcCtD
Gabapentin—Headache—Metformin—polycystic ovary syndrome	0.00157	0.00352	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00154	0.00538	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.0015	0.00524	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.0015	0.00524	CbGpPWpGaD
Gabapentin—Nausea—Metformin—polycystic ovary syndrome	0.00149	0.00334	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00148	0.00518	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00145	0.00506	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00144	0.00504	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00141	0.00494	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00141	0.00493	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.0014	0.00491	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.0014	0.00488	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00137	0.00479	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TEAD2—polycystic ovary syndrome	0.00137	0.00479	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00136	0.00476	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00133	0.00463	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00132	0.00461	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00131	0.00458	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00127	0.00444	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00127	0.00444	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00125	0.00438	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—DLG4—polycystic ovary syndrome	0.00125	0.00437	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00123	0.00429	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00118	0.00413	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00115	0.00402	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00115	0.00402	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00114	0.004	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00112	0.00392	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00111	0.00388	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0011	0.00384	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SRD5A1—polycystic ovary syndrome	0.00109	0.00381	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPCAT2—polycystic ovary syndrome	0.00105	0.00367	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SUOX—polycystic ovary syndrome	0.00105	0.00367	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00104	0.00363	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—STAR—polycystic ovary syndrome	0.00104	0.00363	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00102	0.00355	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.001	0.00351	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000977	0.00341	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000967	0.00338	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000955	0.00334	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000934	0.00326	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMMR—polycystic ovary syndrome	0.000926	0.00324	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000923	0.00322	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000919	0.00321	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.0009	0.00314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.0009	0.00314	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000895	0.00313	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000883	0.00309	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000863	0.00302	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000854	0.00298	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000848	0.00296	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000848	0.00296	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000834	0.00292	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000831	0.0029	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TEAD2—polycystic ovary syndrome	0.000831	0.0029	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000828	0.00289	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LHB—polycystic ovary syndrome	0.000806	0.00282	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0008	0.0028	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.0008	0.00279	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000793	0.00277	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000787	0.00275	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00077	0.00269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00077	0.00269	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00077	0.00269	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000763	0.00267	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000749	0.00262	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00072	0.00252	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00071	0.00248	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000702	0.00245	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000699	0.00244	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000696	0.00243	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000686	0.0024	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000681	0.00238	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00068	0.00238	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—RRM2—polycystic ovary syndrome	0.00068	0.00238	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SRD5A1—polycystic ovary syndrome	0.00066	0.00231	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—YAP1—polycystic ovary syndrome	0.000655	0.00229	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000631	0.0022	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—STAR—polycystic ovary syndrome	0.000629	0.0022	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NAMPT—polycystic ovary syndrome	0.000629	0.0022	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000624	0.00218	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000622	0.00217	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000621	0.00217	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000619	0.00216	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000619	0.00216	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000587	0.00205	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000578	0.00202	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000568	0.00198	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000564	0.00197	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMMR—polycystic ovary syndrome	0.000561	0.00196	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000557	0.00195	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000546	0.00191	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000545	0.0019	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00054	0.00189	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000538	0.00188	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000535	0.00187	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000528	0.00184	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000522	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000515	0.0018	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000506	0.00177	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TH—polycystic ovary syndrome	0.0005	0.00175	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000496	0.00173	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000493	0.00172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00049	0.00171	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LHB—polycystic ovary syndrome	0.000488	0.00171	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000486	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000484	0.00169	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000483	0.00169	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000479	0.00167	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000477	0.00167	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000462	0.00161	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000459	0.00161	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000457	0.0016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000455	0.00159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000455	0.00159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000438	0.00153	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000428	0.0015	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000425	0.00149	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000425	0.00149	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000413	0.00144	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—RRM2—polycystic ovary syndrome	0.000412	0.00144	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNAS—polycystic ovary syndrome	0.000408	0.00143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000402	0.0014	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—YAP1—polycystic ovary syndrome	0.000397	0.00139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000392	0.00137	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOR1—polycystic ovary syndrome	0.000389	0.00136	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAMPT—polycystic ovary syndrome	0.000381	0.00133	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000377	0.00132	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000369	0.00129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000366	0.00128	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000356	0.00125	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000356	0.00124	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP17A1—polycystic ovary syndrome	0.00035	0.00122	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—polycystic ovary syndrome	0.000344	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000333	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000326	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000324	0.00113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000313	0.00109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000304	0.00106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TH—polycystic ovary syndrome	0.000303	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FST—polycystic ovary syndrome	0.000297	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000295	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000295	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000293	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00029	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000283	0.000989	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—polycystic ovary syndrome	0.000279	0.000974	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000277	0.000968	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—POMC—polycystic ovary syndrome	0.000275	0.000961	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000274	0.000958	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000274	0.000956	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—polycystic ovary syndrome	0.000273	0.000955	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000271	0.000949	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000268	0.000936	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000265	0.000927	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000259	0.000905	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000254	0.000889	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000252	0.000882	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000248	0.000868	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNAS—polycystic ovary syndrome	0.000247	0.000864	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOR1—polycystic ovary syndrome	0.000236	0.000823	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000236	0.000823	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000232	0.000812	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000223	0.000781	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000222	0.000776	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000211	0.000738	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—polycystic ovary syndrome	0.000208	0.000728	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000208	0.000726	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000206	0.000719	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000191	0.000668	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000191	0.000668	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000184	0.000644	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000182	0.000638	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000178	0.000622	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000177	0.000619	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—polycystic ovary syndrome	0.000169	0.00059	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000168	0.000588	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000167	0.000585	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000167	0.000583	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—polycystic ovary syndrome	0.000167	0.000582	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—polycystic ovary syndrome	0.000166	0.000579	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000161	0.000562	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000158	0.000553	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000147	0.000513	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00014	0.000489	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000137	0.00048	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000118	0.000411	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000115	0.000402	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000103	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—polycystic ovary syndrome	9.88e-05	0.000345	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—polycystic ovary syndrome	9.83e-05	0.000343	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.51e-05	0.000332	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.5e-05	0.000332	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.03e-05	0.000315	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.27e-05	0.000254	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.21e-05	0.000217	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—polycystic ovary syndrome	4.29e-05	0.00015	CbGpPWpGaD
